Literature DB >> 33742069

Crowdsourcing digital health measures to predict Parkinson's disease severity: the Parkinson's Disease Digital Biomarker DREAM Challenge.

Solveig K Sieberts1, Jennifer Schaff2, Marlena Duda3, Bálint Ármin Pataki4, Ming Sun5, Phil Snyder6, Jean-Francois Daneault7,8, Federico Parisi7,9, Gianluca Costante7,9, Udi Rubin10, Peter Banda11, Yooree Chae6, Elias Chaibub Neto6, E Ray Dorsey12, Zafer Aydın13, Aipeng Chen14, Laura L Elo15, Carlos Espino10, Enrico Glaab11, Ethan Goan16, Fatemeh Noushin Golabchi7, Yasin Görmez13, Maria K Jaakkola15,17, Jitendra Jonnagaddala18,19, Riku Klén15, Dongmei Li20, Christian McDaniel21,22, Dimitri Perrin23, Thanneer M Perumal6, Nastaran Mohammadian Rad24,25,26, Erin Rainaldi27, Stefano Sapienza7, Patrick Schwab28, Nikolai Shokhirev10, Mikko S Venäläinen15, Gloria Vergara-Diaz7, Yuqian Zhang29, Yuanjia Wang30, Yuanfang Guan3, Daniela Brunner10,31, Paolo Bonato7,9, Lara M Mangravite6, Larsson Omberg32.   

Abstract

Consumer wearables and sensors are a rich source of data about patients' daily disease and symptom burden, particularly in the case of movement disorders like Parkinson's disease (PD). However, interpreting these complex data into so-called digital biomarkers requires complicated analytical approaches, and validating these biomarkers requires sufficient data and unbiased evaluation methods. Here we describe the use of crowdsourcing to specifically evaluate and benchmark features derived from accelerometer and gyroscope data in two different datasets to predict the presence of PD and severity of three PD symptoms: tremor, dyskinesia, and bradykinesia. Forty teams from around the world submitted features, and achieved drastically improved predictive performance for PD status (best AUROC = 0.87), as well as tremor- (best AUPR = 0.75), dyskinesia- (best AUPR = 0.48) and bradykinesia-severity (best AUPR = 0.95).

Entities:  

Year:  2021        PMID: 33742069      PMCID: PMC7979931          DOI: 10.1038/s41746-021-00414-7

Source DB:  PubMed          Journal:  NPJ Digit Med        ISSN: 2398-6352


  13 in total

1.  Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.

Authors:  J E Ahlskog; M D Muenter
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

Review 2.  Gender differences in Parkinson's disease: clinical characteristics and cognition.

Authors:  Ivy N Miller; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

3.  PERSONALIZED HYPOTHESIS TESTS FOR DETECTING MEDICATION RESPONSE IN PARKINSON DISEASE PATIENTS USING iPHONE SENSOR DATA.

Authors:  Elias Chaibub Neto; Brian M Bot; Thanneer Perumal; Larsson Omberg; Justin Guinney; Mike Kellen; Arno Klein; Stephen H Friend; Andrew D Trister
Journal:  Pac Symp Biocomput       Date:  2016

4.  Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score.

Authors:  Andong Zhan; Srihari Mohan; Christopher Tarolli; Ruth B Schneider; Jamie L Adams; Saloni Sharma; Molly J Elson; Kelsey L Spear; Alistair M Glidden; Max A Little; Andreas Terzis; E Ray Dorsey; Suchi Saria
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

5.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

6.  The self-assessment trap: can we all be better than average?

Authors:  Raquel Norel; John Jeremy Rice; Gustavo Stolovitzky
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

7.  Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.

Authors:  Florian Lipsmeier; Kirsten I Taylor; Timothy Kilchenmann; Detlef Wolf; Alf Scotland; Jens Schjodt-Eriksen; Wei-Yi Cheng; Ignacio Fernandez-Garcia; Juliane Siebourg-Polster; Liping Jin; Jay Soto; Lynne Verselis; Frank Boess; Martin Koller; Michael Grundman; Andreas U Monsch; Ronald B Postuma; Anirvan Ghosh; Thomas Kremer; Christian Czech; Christian Gossens; Michael Lindemann
Journal:  Mov Disord       Date:  2018-04-27       Impact factor: 10.338

8.  Detecting the impact of subject characteristics on machine learning-based diagnostic applications.

Authors:  Elias Chaibub Neto; Abhishek Pratap; Thanneer M Perumal; Meghasyam Tummalacherla; Phil Snyder; Brian M Bot; Andrew D Trister; Stephen H Friend; Lara Mangravite; Larsson Omberg
Journal:  NPJ Digit Med       Date:  2019-10-11

9.  Accelerometer data collected with a minimum set of wearable sensors from subjects with Parkinson's disease.

Authors:  Jean-Francois Daneault; Gloria Vergara-Diaz; Federico Parisi; Chen Admati; Christina Alfonso; Matilde Bertoli; Edoardo Bonizzoni; Gabriela Ferreira Carvalho; Gianluca Costante; Eric Eduardo Fabara; Naama Fixler; Fatemah Noushin Golabchi; John Growdon; Stefano Sapienza; Phil Snyder; Shahar Shpigelman; Lewis Sudarsky; Margaret Daeschler; Lauren Bataille; Solveig K Sieberts; Larsson Omberg; Steven Moore; Paolo Bonato
Journal:  Sci Data       Date:  2021-02-05       Impact factor: 6.444

10.  The mPower study, Parkinson disease mobile data collected using ResearchKit.

Authors:  Brian M Bot; Christine Suver; Elias Chaibub Neto; Michael Kellen; Arno Klein; Christopher Bare; Megan Doerr; Abhishek Pratap; John Wilbanks; E Ray Dorsey; Stephen H Friend; Andrew D Trister
Journal:  Sci Data       Date:  2016-03-03       Impact factor: 6.444

View more
  3 in total

1.  Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson's disease.

Authors:  Kaiwen Deng; Yueming Li; Hanrui Zhang; Jian Wang; Roger L Albin; Yuanfang Guan
Journal:  Commun Biol       Date:  2022-01-17

Review 2.  Leveraging the Potential of Digital Technology for Better Individualized Treatment of Parkinson's Disease.

Authors:  Holger Fröhlich; Noémi Bontridder; Dijana Petrovska-Delacréta; Enrico Glaab; Felix Kluge; Mounim El Yacoubi; Mayca Marín Valero; Jean-Christophe Corvol; Bjoern Eskofier; Jean-Marc Van Gyseghem; Stepháne Lehericy; Jürgen Winkler; Jochen Klucken
Journal:  Front Neurol       Date:  2022-02-28       Impact factor: 4.003

Review 3.  Translational precision medicine: an industry perspective.

Authors:  Dominik Hartl; Valeria de Luca; Anna Kostikova; Jason Laramie; Scott Kennedy; Enrico Ferrero; Richard Siegel; Martin Fink; Sohail Ahmed; John Millholland; Alexander Schuhmacher; Markus Hinder; Luca Piali; Adrian Roth
Journal:  J Transl Med       Date:  2021-06-05       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.